Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Ng HJ
,
Whittemore ER
,
Tran MB
,
Hogenkamp DJ
,
Broide RS
,
Johnstone TB
,
Zheng L
,
Stevens KE
,
Gee KW
.
???displayArticle.abstract???
Activation of brain alpha7 nicotinic acetylcholine receptors (alpha7 nAChRs) has broad therapeutic potential in CNS diseases related to cognitive dysfunction, including Alzheimer's disease and schizophrenia. In contrast to direct agonist activation, positive allosteric modulation of alpha7 nAChRs would deliver the clinically validated benefits of allosterism to these indications. We have generated a selective alpha7 nAChR-positive allosteric modulator (PAM) from a library of GABAA receptor PAMs. Compound 6 (N-(4-chlorophenyl)-alpha-[[(4-chloro-phenyl)amino]methylene]-3-methyl-5-isoxazoleacet-amide) evokes robust positive modulation of agonist-induced currents at alpha7 nAChRs, while preserving the rapid native characteristics of desensitization, and has little to no efficacy at other ligand-gated ion channels. In rodent models, it corrects sensory-gating deficits and improves working memory, effects consistent with cognitive enhancement. Compound 6 represents a chemotype for allosteric activation of alpha7 nAChRs, with therapeutic potential in CNS diseases with cognitive dysfunction.
Adriani,
N-methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes.
1998, Pubmed
Adriani,
N-methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes.
1998,
Pubmed
Alkondon,
Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons.
1997,
Pubmed
Arai,
Involvement of ERK MAP kinase in endoplasmic reticulum stress in SH-SY5Y human neuroblastoma cells.
2004,
Pubmed
Bettany,
Ventral hippocampal alpha 7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial-arm maze.
2001,
Pubmed
Bowie,
Treatment of cognitive deficits in schizophrenia.
2006,
Pubmed
Charpantier,
Alpha7 neuronal nicotinic acetylcholine receptors are negatively regulated by tyrosine phosphorylation and Src-family kinases.
2005,
Pubmed
,
Xenbase
Christopoulos,
Allosteric binding sites on cell-surface receptors: novel targets for drug discovery.
2002,
Pubmed
Connolly,
The Cys-loop superfamily of ligand-gated ion channels: the impact of receptor structure on function.
2004,
Pubmed
Craig,
Stable expression and characterisation of a human alpha 7 nicotinic subunit chimera: a tool for functional high-throughput screening.
2004,
Pubmed
,
Xenbase
Freedman,
Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia.
1995,
Pubmed
Gotti,
Human neuronal nicotinic receptors.
1997,
Pubmed
Guan,
Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease.
2000,
Pubmed
Hawkinson,
3 alpha-Hydroxy-3 beta-trifluoromethyl-5 alpha-pregnan-20-one (Co 2-1970): a partial agonist at the neuroactive steroid site of the gamma-aminobutyric acidA receptor.
1996,
Pubmed
,
Xenbase
Hurst,
A novel positive allosteric modulator of the alpha7 neuronal nicotinic acetylcholine receptor: in vitro and in vivo characterization.
2005,
Pubmed
,
Xenbase
Johnstone,
Modifying quinolone antibiotics yields new anxiolytics.
2004,
Pubmed
Kitagawa,
Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers.
2003,
Pubmed
Krause,
Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor.
1998,
Pubmed
,
Xenbase
Levin,
Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization.
2006,
Pubmed
Levin,
AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats.
1999,
Pubmed
Lukas,
Neurotoxicity of channel mutations in heterologously expressed alpha7-nicotinic acetylcholine receptors.
2001,
Pubmed
Maelicke,
Allosteric modulation of nicotinic receptors as a treatment strategy for Alzheimer's disease.
2000,
Pubmed
Martin,
Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.
2004,
Pubmed
Mazurov,
Selective alpha7 nicotinic acetylcholine receptor ligands.
2006,
Pubmed
Morris,
PCP: from pharmacology to modelling schizophrenia.
2005,
Pubmed
Möhler,
A new benzodiazepine pharmacology.
2002,
Pubmed
Newhouse,
Effects of nicotinic stimulation on cognitive performance.
2004,
Pubmed
Olincy,
Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia.
2006,
Pubmed
Orr-Urtreger,
Mice homozygous for the L250T mutation in the alpha7 nicotinic acetylcholine receptor show increased neuronal apoptosis and die within 1 day of birth.
2000,
Pubmed
,
Xenbase
Orrenius,
Regulation of cell death: the calcium-apoptosis link.
2003,
Pubmed
Ortega-Alvaro,
Influence of chronic treatment with olanzapine, clozapine and scopolamine on performance of a learned 8-arm radial maze task in rats.
2006,
Pubmed
Picciotto,
Nicotine as a modulator of behavior: beyond the inverted U.
2003,
Pubmed
Placzek,
An alpha7 nicotinic acetylcholine receptor gain-of-function mutant that retains pharmacological fidelity.
2005,
Pubmed
,
Xenbase
Revah,
Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor.
1991,
Pubmed
,
Xenbase
Samochocki,
Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors.
2003,
Pubmed
Stevens,
Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains.
1996,
Pubmed
Stevens,
Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice.
1998,
Pubmed
Texidó,
Effect of galantamine on the human alpha7 neuronal nicotinic acetylcholine receptor, the Torpedo nicotinic acetylcholine receptor and spontaneous cholinergic synaptic activity.
2005,
Pubmed
,
Xenbase
Whittemore,
Pharmacology of the human gamma-aminobutyric acidA receptor alpha 4 subunit expressed in Xenopus laevis oocytes.
1996,
Pubmed
,
Xenbase
Young,
Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice.
2007,
Pubmed
Zwart,
5-Hydroxyindole potentiates human alpha 7 nicotinic receptor-mediated responses and enhances acetylcholine-induced glutamate release in cerebellar slices.
2002,
Pubmed
,
Xenbase
